Skip to main content
SpringerLink
Log in

Hyperuricemia and other Cardiovascular Risk Factors

  • Chapter
Purine Metabolism in Man—II

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 76B))

Abstract

The prevalence of clinical gout is rather low in Finland. In most studies concerning the epidemiology of gout the prevalence rates have varied from 0.3 to 3.0% in adult population. Persons having certain chronic diseases are allowed free drug therapy according to the Sickness Insurance Act of Finland. Gout is one of these chronic diseases. According to the latest statistics 0.1% of men and 0.03% of women aged 35–64 years are allowed free drug therapy for gout(1). On the other hand, the serum uric acid concentration of Finnish population is not strikingly lower than in other countries (2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Statistics on drugs reimbursed in full 30.6.1974. Social Insurance Institution’s publication T6:7, Helsinki 1974. (in Finnish)

    Google Scholar 

  2. Isomäki, H.: Hyp:eruricaemia in northern Finland. Ann. clin. Res. suppl. 1. 1969.

    Google Scholar 

  3. Hall, A.P.: Correlations among hyperuricaemia, hypercholesterolemia, coronary disease and hypertension. Arthr. Rheum. 8:846, 1965.

    Article  CAS  Google Scholar 

  4. Klein, R. et al.: Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch. int. med. 32:401, 1973.

    Article  Google Scholar 

  5. Pearre, J. et al.: Uric acid and plasma lipids in cerebrovascular disease. Brit. med. J. 4: 78, 1969.

    Article  Google Scholar 

  6. Bulpitt, C.J.: Serum uric acid in hypertensive patients. Brit. Heart J. 37:1210, 1975.

    Article  PubMed  CAS  Google Scholar 

  7. Pyörälä, K. et al.: Social Insurance Institution’s coronary heart disease study. Social Insurance Institution’s publications AL 1, Helsinki 1975. (in Finnish with English summary)

    Google Scholar 

  8. Takkunen, H.: Iron deficiency in the Finnish adult population. Scand. J. Haemat. suppl. 25, 1976.

    Google Scholar 

  9. Uric acid method. In Auto-Analyzer Manual. Technicon Instruments Corp. Chauncey, New York 1965.

    Google Scholar 

  10. Andrews, F.M. et al.: “Multiple classification analysis”. 2nd ed. Ann Arbor, Institute for Social Research, The University of Michigan, 1973.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Research Institute for Social Security and the Division of Epidemiology and Preventive Medicine, the Social Insurance Institution, Helsinki, Finland

    Heikki Takkunen & Antti Reunanen

Authors
  1. Heikki Takkunen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antti Reunanen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Vienna, Vienna, Austria

    Mathias M. Müller  & Erich Kaiser  & 

  2. University of California, San Diego, La Jolla, California, USA

    J. Edwin Seegmiller

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Plenum Press, New York

About this chapter

Cite this chapter

Takkunen, H., Reunanen, A. (1977). Hyperuricemia and other Cardiovascular Risk Factors. In: Müller, M.M., Kaiser, E., Seegmiller, J.E. (eds) Purine Metabolism in Man—II. Advances in Experimental Medicine and Biology, vol 76B. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3285-5_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-3285-5_34

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-3287-9

  • Online ISBN: 978-1-4684-3285-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation